Status:
UNKNOWN
Endoscopic Third Ventriculostomy for Adults: A Prognostic Model for Success
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Hydrocephalus
Eligibility:
All Genders
18+ years
Brief Summary
Endoscopic Third Ventriculostomy for Adults with Hydrocephalus: Creating a Prognostic Model for Success - A Retrospective Multicenter Study Background: Endoscopic third ventriculostomy (ETV) is becom...
Detailed Description
Endoscopic Third Ventriculostomy for Adults with Hydrocephalus: Creating a Prognostic Model for Success - a retrospective multicenter study Background: The most common treatment for hydrocephalus is...
Eligibility Criteria
Inclusion
- ETV procedure performed
- ≥18 years old at time of first ETV
Exclusion
- \<18 years old at time of first ETV
- Permanent intraventricular foreign bodies left behind after the ETV. eg. Shunt or stents. Temporary external ventricular drains, ICP-monitoring probes or ligated shunts where the ventricular drain is removed, are not excluded.
Key Trial Info
Start Date :
May 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04773938
Start Date
May 27 2020
End Date
August 1 2022
Last Update
May 3 2022
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurosurgery, Aalborg University Hospital
Aalborg, Denmark
2
Department of Neurosurgery, Aarhus University Hospital
Aarhus, Denmark
3
Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet
Copenhagen, Denmark
4
Department of Neurosurgery, Odense University Hospital
Odense, Denmark